1. Home
  2. CLB vs CMPX Comparison

CLB vs CMPX Comparison

Compare CLB & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Core Laboratories Inc.

CLB

Core Laboratories Inc.

HOLD

Current Price

$10.46

Market Cap

502.0M

Sector

N/A

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$1.14

Market Cap

408.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLB
CMPX
Founded
1936
2014
Country
United States
United States
Employees
3300
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
502.0M
408.8M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
CLB
CMPX
Price
$10.46
$1.14
Analyst Decision
Hold
Strong Buy
Analyst Count
2
9
Target Price
$12.50
★ $14.57
AVG Volume (30 Days)
410.3K
★ 3.8M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
★ 0.23%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.11
N/A
Revenue
★ $526,520,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.75
$934.41
P/E Ratio
$96.64
★ N/A
Revenue Growth
★ 0.51
N/A
52 Week Low
$9.79
$1.13
52 Week High
$20.36
$6.88

Technical Indicators

Market Signals
Indicator
CLB
CMPX
Relative Strength Index (RSI) 31.33 18.41
Support Level $10.58 N/A
Resistance Level $12.11 $2.13
Average True Range (ATR) 0.48 0.11
MACD -0.20 -0.11
Stochastic Oscillator 8.23 1.44

Price Performance

Historical Comparison
CLB
CMPX

About CLB Core Laboratories Inc.

Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: